Impax Asset Management Group plc Purchases 890,040 Shares of Itron, Inc. $ITRI

Impax Asset Management Group plc raised its holdings in Itron, Inc. (NASDAQ:ITRIFree Report) by 127.3% in the third quarter, Holdings Channel reports. The fund owned 1,588,950 shares of the scientific and technical instruments company’s stock after acquiring an additional 890,040 shares during the period. Itron accounts for about 1.2% of Impax Asset Management Group plc’s portfolio, making the stock its 26th biggest position. Impax Asset Management Group plc’s holdings in Itron were worth $197,153,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. EverSource Wealth Advisors LLC grew its stake in Itron by 25.3% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 401 shares of the scientific and technical instruments company’s stock worth $53,000 after acquiring an additional 81 shares during the period. Amalgamated Bank lifted its stake in shares of Itron by 0.7% during the 3rd quarter. Amalgamated Bank now owns 13,060 shares of the scientific and technical instruments company’s stock worth $1,627,000 after purchasing an additional 86 shares during the period. PFG Investments LLC boosted its holdings in shares of Itron by 4.8% during the third quarter. PFG Investments LLC now owns 2,059 shares of the scientific and technical instruments company’s stock worth $256,000 after purchasing an additional 94 shares during the last quarter. Elevation Point Wealth Partners LLC grew its position in shares of Itron by 3.5% in the second quarter. Elevation Point Wealth Partners LLC now owns 3,398 shares of the scientific and technical instruments company’s stock valued at $447,000 after purchasing an additional 115 shares during the period. Finally, J.W. Cole Advisors Inc. grew its position in shares of Itron by 6.0% in the second quarter. J.W. Cole Advisors Inc. now owns 2,056 shares of the scientific and technical instruments company’s stock valued at $271,000 after purchasing an additional 116 shares during the period. 96.19% of the stock is currently owned by institutional investors.

Itron Trading Up 1.0%

NASDAQ ITRI opened at $105.57 on Wednesday. Itron, Inc. has a one year low of $90.11 and a one year high of $142.00. The company’s 50 day moving average price is $97.96 and its 200 day moving average price is $111.80. The company has a debt-to-equity ratio of 0.46, a quick ratio of 1.91 and a current ratio of 2.17. The firm has a market capitalization of $4.84 billion, a price-to-earnings ratio of 18.99, a PEG ratio of 0.60 and a beta of 1.48.

Insider Buying and Selling

In related news, SVP Justin K. Patrick sold 379 shares of the stock in a transaction on Monday, November 24th. The stock was sold at an average price of $96.51, for a total value of $36,577.29. Following the completion of the sale, the senior vice president directly owned 20,382 shares in the company, valued at approximately $1,967,066.82. This represents a 1.83% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Donald L. Reeves III sold 536 shares of the firm’s stock in a transaction dated Monday, November 24th. The shares were sold at an average price of $96.51, for a total value of $51,729.36. Following the completion of the transaction, the senior vice president directly owned 19,068 shares in the company, valued at $1,840,252.68. This trade represents a 2.73% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders have sold 2,971 shares of company stock valued at $286,731. 1.51% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on the company. Zacks Research downgraded Itron from a “hold” rating to a “strong sell” rating in a research report on Wednesday, January 28th. Oppenheimer dropped their price objective on shares of Itron from $145.00 to $125.00 and set an “outperform” rating for the company in a research note on Tuesday, January 27th. Johnson Rice upgraded shares of Itron from an “accumulate” rating to a “buy” rating and set a $130.00 price objective on the stock in a report on Monday, January 5th. Wall Street Zen cut shares of Itron from a “buy” rating to a “hold” rating in a research report on Wednesday, January 14th. Finally, Weiss Ratings downgraded shares of Itron from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday, January 12th. Eight investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $136.10.

Get Our Latest Stock Analysis on Itron

Itron Profile

(Free Report)

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.

Read More

Want to see what other hedge funds are holding ITRI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Itron, Inc. (NASDAQ:ITRIFree Report).

Institutional Ownership by Quarter for Itron (NASDAQ:ITRI)

Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.